6-Bromo-1H-Indazole-3-Carbonitrile: A Fresh Look at an Indazole Intermediate

Understanding the Chemical and Its Potential

With more advanced chemistry at our fingertips, research teams and process developers often search for intermediates that can improve synthesis paths or offer new possibilities. Among these, 6-Bromo-1H-Indazole-3-Carbonitrile (CAS 223325-39-1) steps into the spotlight for its balance of reactivity and selectivity. Labs working on pharmaceutical targets or specialty chemicals know that finding molecules capable of multiple transformation routes means less time lost, more chances to screen derivatives, and sometimes a few less headaches from stubborn byproducts.

The backbone here, an indazole core ring, shows up in multiple biologically relevant compounds and patented drug leads, from kinase inhibitors to CNS agents. The bromine atom at the 6-position and a nitrile group at the 3-position open up a world of routes for chemical innovation. With over a decade working in synthetic and medicinal laboratories, I remember projects where similar building blocks nudged stalled efforts past seemingly dead ends. Sometimes a small substitution at the right spot means the difference between a promising new candidate and an all-too-familiar string of failed batches.

What Makes This Compound Stand Out

Let’s dig into the nuts and bolts. On the market, you’ll spot a range of indazole derivatives. Most lack the dual functionality this one offers. The bromo group brings easy entry to Suzuki and Buchwald-Hartwig couplings—reactions that let chemists swap in aromatic rings or amines with precision. The nitrile serves double-duty: it helps with polarity and can transform under mild conditions into a variety of motifs, including amides, tetrazoles, or carboxylic acids. Anyone dealing with multi-step synthesis values a handle that offers choice, especially since early-stage building blocks have a habit of dictating every step down the line, for better or worse.

Quality and consistency matter, especially once scale-up enters the picture. Reliable suppliers deliver 6-Bromo-1H-Indazole-3-Carbonitrile at purities above 98 percent, most often as a pale powder. Handling and dissolution follow standard protocol for indazole derivatives. Shipping and storage work best in tightly sealed containers, away from moisture and sunlight. This stability simplifies life for operations and QC teams, who often scramble to juggle less cooperative molecules.

Use Cases in Modern Research

From college benches to high-throughput industrial settings, this compound gets pulled off the shelf for several reasons. Drug discovery teams often use it as an intermediate for producing kinase inhibitors. The indazole core structure persists in modern kinase-targeted therapies, and researchers frequently cite the need for flexible substituents at positions 3 and 6. Here, the combination of nitrile and bromine allows rapid parallel synthesis—chemists can generate compound libraries by mixing and matching new substituents without reinventing the early synthetic steps every time.

Material science and agrochemical sectors haven’t ignored this molecule either. Nitrile-containing heterocycles appear across many functional materials and advanced crop protection agents. Performance in these areas often comes down to subtle modifications. In some real-world programs, a single atom change at an aromatic position swung compound selectivity, while the core scaffold kept the synthesis robust and predictable under scale-up conditions.

Comparing to Similar Indazole Derivatives

Not every indazole derivative delivers the same agility for downstream chemistry. Take, for instance, simple 1H-indazole: it lacks activation sites. Derivatives with only a bromo, or only a nitrile, require extra protection–deprotection strategies or harsher reagents to achieve modifications. Rival compounds, such as 3-bromo-indazole derivatives or 6-cyano-indazoles, also limit flexibility since certain reactions prefer substituent orientation or electronic effects. Through my own pursuits, these bottlenecks often meant revised project timelines and new rounds of purchasing, dramatically affecting project budgets and team morale.

In medicinal chemistry, dual-substituted indazoles like 6-Bromo-1H-Indazole-3-Carbonitrile bridge the gap between generic, less functionalized compounds and highly elaborate, bespoke scaffolds. The nitrile at the 3-position draws in those needing a handle for additional reactions or for docking in protein binding sites. Meanwhile, the bromo group delivers the all-important gateway to cross-couplings. Teams with complex target profiles appreciate shaving synthesis steps wherever possible. If you’re comparing cost-to-benefit across indazole intermediates, this compound often offers better return by reducing time spent on protection strategies or purification stages.

Trust and Consistency: Meeting Quality Demands

Modern regulatory frameworks keep expectations high for traceability and characterization. For any research or manufacturing campaign, batch-to-batch consistency isn’t just nice to have—it's table stakes. Reliable sources for 6-Bromo-1H-Indazole-3-Carbonitrile supply analytical data (such as NMR and HPLC) to verify purity and identify minor impurities. Those working under GMP or ISO-style rigor can expect proper packaging, COAs, and a history of lot performance, especially for scale-ups beyond a few grams.

In my experience bridging small-to-midsize synthesis and larger production environments, I’ve seen months lost due to ambiguous impurity data or documentation gaps. Reputable suppliers with clear batch histories and fast turnaround for technical questions grant a sense of security, freeing up researchers to focus on innovation over bureaucracy. This becomes critical when regulatory filings require a watertight audit trail and the ability to demonstrate precise sourcing.

Practical Handling and Safety Notes

Despite chemical progress, best practices don’t go out of style. Teams working with 6-Bromo-1H-Indazole-3-Carbonitrile adhere to standard PPE: gloves, lab coats, and eye protection during handling and transfer. Reports of volatility, reactivity with mild bases or acids, or challenging odor issues remain rare, which makes day-to-day operations smoother. Material safety data typically flags the compound as a moderate irritant, and standard waste protocols for brominated aromatics apply for both liquid and solid residues. Chemists value compounds that don't surprise them with odd stabilities or tendency to polymerize—traits well-documented for this molecule.

Facilities also monitor air handling and local exhaust to minimize inhalation exposure, especially during powder feeding or transfers to reactors. After a decade in lab settings, I’ve watched safety routines tighten, driven by a blend of regulation and simple practicality; nobody wants a minor spill to set back a hard-earned milestone.

Real-World Project Examples: Advancing Drug Discovery

In the high-pressure field of early phase drug discovery, even a modest improvement in intermediate chemistry can tip the odds in favor of faster development. When my team needed a way to shuffle substituents onto a heterocyclic template without revising every reaction step, a dual-functional molecule like 6-Bromo-1H-Indazole-3-Carbonitrile proved its worth. Setting up parallel couplings allowed the team to screen more candidates in a shorter window, narrowing in on the potential winners while limiting resource drain.

Many academic groups have turned to this compound when embarking on SAR (structure-activity relationship) campaigns. Having both a bromo and a nitrile makes it possible to design analogues targeting new binding pockets or metabolic stabilities. In project meetings, this translates to more molecules delivered before the next funding review or paper submission—a boon for both grant writers and early career researchers aiming for publication impact.

The Bigger Picture: Why Intermediate Selection Matters

Choosing the right building blocks ripples through every part of the research and development process. In practice, using 6-Bromo-1H-Indazole-3-Carbonitrile can mean fewer headaches during late-stage modifications, since the core offers reactivity at useful positions without making the molecule too busy. Chemical intuition and anecdotal lessons from the lab bench reinforce this: early, thoughtful intermediate selection enables smoother method transfers, easier patent claims, and, perhaps, a more relaxed Friday afternoon.

Consider a pipeline working toward CNS-active agents. The right indazole derivative shapes both pharmacokinetic and patent profiles. Often, downstream deadlines hang in the balance, waiting for a single, tricky step to clear. By picking an intermediate with flexible handles, teams can shift direction much faster—a survival trait in fields where timelines grow shorter every year.

Supply Chain and Market Realities

Over the last several years, global supply for pharmaceutical intermediates has changed rapidly. Production capability for indazole scaffolds now spans North America, Europe, and parts of Asia, letting procurement managers seek out suppliers who balance pricing, documentation, and logistics support. During pandemic disruptions, those with robust chains for key intermediates kept research and pilot scale lines moving even as others faced delays.

With environmental, social, and governance considerations on the rise, more companies screen intermediates for not just purity and yield, but supplier transparency and sustainable practices. In my own projects, choosing partners with proven track records in green chemistry, safe waste handling, and reproducible delivery often mattered more than shaving a few dollars off per gram—especially if a late delivery could stall a regulatory submission.

Next Steps in Synthesis: Making the Most of Dual Functionality

For those facing scale-up or process optimization, the dual functionality of 6-Bromo-1H-Indazole-3-Carbonitrile really pays off. Suzuki and Buchwald-Hartwig reactions flourish with this scaffold, allowing researchers to explore aryl or amine substitutions under mild, scalable conditions. The nitrile, meanwhile, opens doors for further elaboration with strong selectivity. Whether configuring a three-stage process or plugging into a more elaborate route, flexibility at both functional sites delivers options—an invaluable resource as final product specs oscillate and regulatory standards shift.

Process chemists, always on the hunt for fewer steps and greener routes, appreciate that this compound lets them avoid traditional protecting group gymnastics. With well-established purification routines—chromatography, crystallization, and phase extracts—the calendar can move forward with a bit less worry about sudden bottlenecks. The lessons learned in academic and industrial settings alike echo a basic truth: time spent fighting cumbersome intermediates trickles down through every person, every schedule, and every result that comes next.

Advice from the Trenches: Practical Tips

For those new to working with indazole derivatives, a few simple pointers go a long way. Keep material dry and store it at room temperature or below in a desiccator, avoiding unnecessary freeze-thaw cycles that can invite micro-contamination. Double-check your solvent choices, since not all bromoindazoles dissolve readily in the same mixtures; a little pilot solubility test up front can prevent wasted reagent. Routine use of TLC, LC-MS, or NMR to verify batch identity prevents surprises during scale-up. This practice saved my own teams plenty of time, catching small discrepancies before they cause larger synthesis headaches.

Above all, maintain communication with your supplier. In fields where documentation and traceability can make or break a regulatory filing, getting quick technical responses and up-to-date COAs takes the guesswork out of procurement. That way, all the creative effort can focus on the science itself, not the logistics of getting the right powder in the right bottle.

Moving Forward: Why This Compound Holds Value

Every innovation in synthetic chemistry depends on building blocks that don’t stand in the way. 6-Bromo-1H-Indazole-3-Carbonitrile has steadily earned a reputation as a reliable intermediate because it answers a core set of practical needs. It meets purity and stability standards for industry, responds robustly to a wide range of proven reactions, and fuels cycles of optimization without drawing the synthetic process into complexity for its own sake.

Reflecting on years at the bench and in process meetings, I’ve watched certain compounds fade out as newer, more adaptable intermediates came into favor. This one continues to appear in forward-looking synthesis blueprints, not just because of its chemical structure but for the reliable performance it offers from the first milligram to multi-kilogram lots. It makes a difference, not only in output and budgets but also in the day-to-day creative journey that brings new medicines and materials closer to reality.

Conclusion: Consistent Innovation, Constant Value

Returning time and again to 6-Bromo-1H-Indazole-3-Carbonitrile, research teams find a partner in progress. As challenges in drug discovery and specialty chemicals grow sharper, having an intermediate that opens multiple doors, shaves off steps, and responds predictably to downstream chemistry gives research a vital edge. Its blend of dual functionality, ready availability, and clarity of documentation addresses not just the science but the business of chemistry.

For those crafting the next generation of therapies or exploring high-value materials, small choices in building blocks often echo throughout the entire program. Having seen projects succeed and stumble, I trust that careful attention at the intermediate stage positions teams for better discoveries, fewer detours, and a clearer path from curiosity to commercial impact. In this way, 6-Bromo-1H-Indazole-3-Carbonitrile continues to carve out an essential place on both lab shelves and in forward-thinking synthesis plans.